Skip to main content

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Prediction of Functional Outcomes From Chronic Critical Illness

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Prediction of Functional Outcomes From Chronic Critical Illness

Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 226
  • Page 227
  • Page 228
  • Page 229
  • Page 230
  • Page 231
  • Page 232
  • Page 233
  • Page 234
  • …
  • Next page Next
  • Last page Last
Subscribe to